Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells

Mast cell degranulation plays a pivotal role in urticaria and is also an early histologic characteristic of psoriasis. However, whether the activation of mast cells contributes to psoriasis recurrence after discontinuation of interleukin (IL)-17A blockers remains unclear.